Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Body & Mind ( (TSE:BAMM) ) has provided an update.
Body and Mind Inc. announced a need to restate its financial statements for certain periods in 2023 and 2024 due to misstatements related to a variable interest entity and unrecorded management fee income. These financial discrepancies were deemed material on a cumulative basis, prompting the company to amend its previously issued financial statements. The amendments are pending final procedures, including external accounting approvals and quality control sign-offs, which may impact stakeholders’ trust and the company’s financial integrity.
More about Body & Mind
Body and Mind Inc. is a cannabis company focused on operations and retail cannabis dispensaries in California, with pending operations in New Jersey. The company aims to increase market share by enhancing customer satisfaction and operational efficiencies, with an emphasis on return on investment projects, especially new retail store launches in Illinois and New Jersey.
YTD Price Performance: -35.00%
Average Trading Volume: 46,062
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.58M
See more insights into BAMM stock on TipRanks’ Stock Analysis page.
